Catherine A. Sohn Jazz Pharmaceuticals PLC (JAZZ) insider trading activity
Catherine A. Sohn is Director of Jazz Pharmaceuticals plc. Currently has a direct ownership of 14,868 shares of JAZZ, which is worth approximately $1.87 Million. The most recent transaction as insider was on Aug 14, 2023, when has been sold 1,241 shares (Ordinary Shares) at a price of $138.16 per share, resulting in proceeds of $171,456. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
14.9K
0%
3M change
0%
12M change
Total Value Held
$1.87 Million
Catherine A. Sohn Transaction History
Also insider at
CAS
Catherine A. Sohn
Director
Dublin 4, L2